Guy Webber, BSc (Hons), MSc (Dist)

Scientific Manager, In Vitro and Drug-Drug Interaction Sciences

Envigo

Approaches for Reducing Liability to Major Metabolically-Driven Causes of Drug Attrition - The Challenge to De-Risk Pharmaceuticals
Saturday, February 10, 2018
For every 10,000 molecules entering drug discovery, 9,999 will fail during some stage of the development process and only one will become a successful marketed drug (and even then, it is not certain development costs will be recouped).